Results 101 to 110 of about 63,633 (261)

Radical pericardiectomy for chronic constrictive pericarditis

open access: yesJournal of cardiac surgery, 2018
We studied the impact of radical pericardiectomy on early and long‐term patient survival, postoperative New York Heart Association (NYHA) functional class, and left ventricular ejection fraction in patients with chronic constrictive pericarditis compared
S. Nozohoor   +3 more
semanticscholar   +1 more source

Ascitic Fluid Analysis Leading to the Diagnosis of Constrictive Pericarditis in 2 Patients

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Although well documented, constrictive pericarditis is a rare entity and an uncommon cause of heart failure. A stiff and noncompliant pericardium creates the disease’s unique hemodynamics and leads to elevated venous pressures, hepatic sinusoidal ...
Sarah Barbina MD   +4 more
doaj   +1 more source

Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis

open access: yesWorld Journal of Cardiology, 2018
This review article aims to: (1) discern from the literature the immune and inflammatory processes occurring in the pericardium following injury; and (2) to delve into the molecular mechanisms which may play a role in the progression to constrictive ...
Vinasha Ramasamy   +3 more
semanticscholar   +1 more source

Rituximab and pericardiectomy with waffle procedure in constrictive pericarditis due to IgG4‐related disease: A case report

open access: yesClinical Case Reports
Key Clinical Message We should consider IgG4‐related disease (IGRD) as one of the potential causes of constrictive pericarditis. In patients with constrictive pericarditis due to IGRD, the combination of surgical treatment and immunosuppressive therapy ...
Toshitaka Okabe   +9 more
doaj   +1 more source

Chylous ascites and chylothorax due to constrictive pericarditis in a patient infected with HIV: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Chylothorax and chylous ascites are uncommon and usually associated with trauma or neoplasms. To the best of our knowledge, constrictive pericarditis leading to chylothorax and chylous ascites in a person infected with HIV has never ...
Summachiwakij Sarawut   +3 more
doaj   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

Dosimetric assessment of conventional and advanced algorithms in clinical stereotactic radiotherapy

open access: yesPrecision Radiation Oncology, EarlyView.
A comprehensive comparison of Type B (Ray Tracing, AAA) and Type C (Monte Carlo, Acuros XB) algorithms in 125 SRT/SBRT cases across homogeneous and heterogeneous tissues using CyberKnife and Varian systems. In lung cases, Type B algorithms overestimated D95% by up to 14%.
Abhay Kumar Singh   +2 more
wiley   +1 more source

Biologics and Small‐Molecule Therapies in Netherton Syndrome: A Comprehensive Review

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Netherton syndrome (NS) is a rare congenital ichthyosis caused by loss‐of‐function mutations in the SPINK5 gene, leading to defective expression of the serine protease inhibitor LEKTI. Dysregulated epidermal protease activity results in impaired skin barrier function and chronic inflammation, accompanied by complex immune profiles. NS patients
Shin Morizane   +6 more
wiley   +1 more source

Echocardiography-Based Deep Learning Model to Differentiate Constrictive Pericarditis and Restrictive Cardiomyopathy.

open access: yesJACC Cardiovascular Imaging, 2023
Chieh-Ju Chao   +12 more
semanticscholar   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy